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ABSTRACT
These studies demonstrate that the MH 1C1 strain of rat hepatoma cells has the ability to
take up and conjugate bilirubin and then excrete the conjugated pigment into the culture
medium. On incubation with unconjugated bilirubin, the average rate of appearance of
conjugated bilirubin in the medium was 4.4 f 0.20 µg per mg of cell protein per hour
(mean f sE). The products formed from bilirubin by MH1C1 cells were chromatogra
y phically identical to those found in normal rat bile. Assay of bilirubin UDP glucuronyl
transferase activity in homogenates of MH1C1 cells gave a value of 3.3 ± 0.50 µg of con
jugated pigment formed per mg protein per hour, only moderately less than the enzyme
activity of liver from normal rats . Rat fibroblasts in culture did not conjugate bilirubin,
nor did they contain bilirubin UDP-glucuronyl transferase activity. As in living animals,
flavaspidic acid inhibited bilirubin metabolism by MH 1C1 cells, suggesting that the mech-
anism for bilirubin uptake is similar to that of normal liver. In contrast to the findings in
animals, however, preincubation of MH 1C1 cells with phenobarbital led to only minimal
enhancement of pigment conjugation . MH1C1 cells represent the first example of a clonal
strain of cells in culture in which many of the pathways of hepatic bilirubin metabolism
remain intact. They should, therefore, serve as a useful model for studies of bile pigment
metabolism which are not easily performed in the living animal.
INTRODUCTION
The movement of bilirubin from plasma to bile few studies reported have been concerned with
involves several processes: uptake of unconjugated cells incapable of conjugating bilirubin (1, 2) .
bilirubin by liver cells, conjugation with glucuronic We have, therefore, investigated bilirubin metab-
acid, and secretion of the conjugated pigment olism in a clonal strain of rat hepatoma cells
into the bile. Despite extensive investigation, the (MH1C1) which performs a number of liver-speci-
mechanisms involved in each of these processes fic functions (3, 4). These cells produce serum
are incompletely understood. Studies of bilirubin albumin (3), tyrosine aminotransferase (4), and
metabolism in hepatic cells in culture would the ninth component of complement (4, 5) . They
circumvent a number of difficulties encountered also conjugate testosterone with glucuronic acid
in experiments with intact animals or with liver (4). Albumin production and the level of tyrosine
slices or homogenates . However, this approach aminotransferase are both stimulated by treat-
has been hamperedd by the lack of a line of cells in ment with hydrocortisone (4, 6).
which bilirubin conjugation remains intact ; the
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703that MH1C1 cells contain the enzyme, bilirubin
UDP-glucuronyl transferase, and are capable of
transforming unconjugated bilirubin to the con-
jugated form at rates comparable to those ob-
served in the liver of intact rats.
MATERIALS AND METHODS
Materials
Unconjugated bilirubin was obtained from the
Sigma Chemical Co., St. Louis, Mo. (Lot No. 88B-
8110). A 50 mg/100 ml solution was made by dissolv-
ing 5 mg of bilirubin rapidly in 0.5 ml 0.05 N NaOH,
followed by addition of 9 .5 ml of a 2.4 g/100 ml solu-
tion of bovine serum albumin (Albumin Bovine
Crystalline, Nutritional Biochemical Corp., Cleve-
land, Ohio, Control No . 8161). Fresh bilirubin solu-
tions were prepared immediately before each experi-
ment.
Flavaspidic acid-N-methylglucaminate was a
gift from Dr. Esa Aho, Laaketehdas Leiras, Turku,
Finland.
Hydrocortisone sodium succinate was obtained
from the Upjohn Company, Kalamazoo, Michigan .
Stock solutions of 9 X 10_4
M hydrocortisone were
made in 0.15 M NaCl and stored at -20 °C for no
more than 1 wk.
Phenobarbital was obtained from Merck and Co.,
Inc., Rahway, New Jersey. It was dissolved freshly
each day in serum-free growth medium at a con-
centration of 4 mg/ml .
Precoated silica gel plates (F-25, 0.25 mm) for
thin-layer chromatography were obtained from
Merck and Co., Inc. (see above).
Viokase was purchased from the VioBin Corpora-
tion, Monticello, Illinois.
Methods
METHODS OF CELL CULTURE : The cells used
in these experiments were derived from the trans-
plantable Morris rat hepatoma No. 7795. They were
established as a clonal strain, MH1C1, by U. I.
Richardson et al. (3), and have been serially propa-
gated since 1967. Cells were grown in 75 sq cm (250
ml) Falcon plastic tissue culture flasks in Ham's F 10
medium (7) supplemented with 15% horse serum
and 2.5% fetal calf serum. A few experiments were
also performed with Dulbecco's modification of
Eagle's medium' (8, 9) supplemented with 100] 0
fetal calf serum and 7.5% horse serum . Cultures
were incubated at 37°C in a humidified atmosphere
of 50 % 0 CO2 and 95% air. Subcultures were made by
' As prepared for Dr. Michael Oxman by Micro-
biological Associates, Inc ., Bethesda, Maryland .
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incubating the cells with 0.1% Viokase solution in
phosphate-buffered saline for 5-10 min at 37 °C.
The dispersed cells were then gently centrifuged and
resuspended in fresh medium.
Control experiments were carried out both with
medium in the absence of cells and with a clonai
strain of rat fibroblasts (R5) grown under the same
conditions as the MHICI cells. Cell protein was
determined by the method of Lowry et al . (10) .
MEASUREMENT OF BILIRUBIN CONJUGATION
BY CELLS IN CULTURE :2 At the beginning of
each experiment the growth medium was removed
and fresh prewarmed medium was added. Bilirubin
solution was then added to give a final bilirubin con-
centration of 1.25-5.0 mg/100 ml in a total incuba-
tion volume of 6.0 ml. All flasks were prepared in
duplicate. Cultures were incubated at 37°C, and
0.25 ml samples were removed at intervals (see Re-
sults) for immediate measurement of the concentra-
tion of conjugated bilirubin.
Conjugated bilirubin was measured as the dia-
zonium salt of ethyl anthranilate, as described by
VanRoy and Heirwegh (11). In one experiment,
conjugated bilirubin was also measured according to
the method of Weber and Schalm (12) ; similar
results were obtained with both assays. Conjugated
bilirubin was further identified in two thin-layer
chromatographic systems . In the first system, 3 native
bile pigments were isolated after precipitation of pro-
teins with a 1 :4 solution of saturated (NH4)2SO4:abso-
lute ethanol. The precipitate was washed several times
with a 1 :1 solution of methanol : chloroform, and the
combined supernatant fractions were evaporated to
dryness in vacuo . The residue was taken up in metha-
nol: chloroform, applied to silica gel plates, and
developed in chloroform : methanol: acetic acid (8.5 :
1.5 :0.3). In this system, unconjugated bilirubin
travels with the solvent front ; conjugated pigment I
(13) moves with an Rt of about 0 .15; and conju-
gated pigment II (13) moves just above the origin .
In the second chromatographic system, pigments
were first diazotized with 2,4-dichloroaniline (14).
The diazo-derivatives were extracted into ethyl ace-
tate, and the latter was washed with water and then
evaporated in vacuo . The pigments were separated on
silica gel plates in a solvent system of isoamylacetate:
propionic acid : N-propanol: water (4:3 :2 :1). The
diazo-derivative of unconjugated bilirubin traveled
2 Although the term "bilirubin conjugation" is used
for convenience, the appearance of conjugated bili-
rubin in the medium actually involves several proc-
esses: uptake of unconjugated bilirubin by the
cells, conjugation with glucuronic acid, and release
of the conjugated pigment into the medium.
3 Based on a personal communication from Dr .
K. P. M. Heirwegh.just behind the solvent front, while that of conjugated
bilirubin had an Rf value of 0.55-0.60. Pigment I
isolated from the first chromatographic system yielded
equal quantities of both azo pigments (13) ; pigment
II yielded only the conjugated product (13).
ASSAY OF BILIRUBIN UDP-GLUCURONYL
TRANSFERASE : In each experiment, the contents
of several identical bottles of cells (a total of 4 .2-14.7
mg cell protein) were pooled for enzyme assay . The
cells were recovered from the culture vessels by in-
cubation with Viokase. They were then centrifuged,
washed once, resuspended in a solution of 0 .25 M
sucrose and 0.001 M EDTA, and frozen at -70°C
until assay, which was usually performed 2-4 days
later. Glucuronyl transferase activity was measured
by the method of VanRoy and Heirwegh (11), as
modified by Black and Billing (15).
INCUBATION WITH DRUGS : In some experi-
ments, either 3 X 10-5 M hydrocortisone or 9.6 X
10-4M phenobarbital was included in the culture me-
dium. Medium was changed every day, with addition
of fresh hydrocortisone or phenobarbital . Formation
of conjugated bilirubin by cells in culture was meas-
ured both during 6-hr incubations with drug and after
8 days of pretreatment with drug . Control measure-
ments were performed with equivalent quantities of
cells from the same subculture which had not been
treated with hydrocortisone or phenobarbital . In
addition, glucuronyl transferase activity in cell
homogenates was measured after 8 days of pretreat-
ment with either drug .
In another experiment, flavaspidic acid-N-methyl-
glucaminate was incorporated into the medium in
final concentrations of 1 and 5 mg/100 ml, and the
formation of conjugated bilirubin was measured over
the ensuing 24 hr. Control measurements were
performed in replicate flasks to which no drug had
been added.
RESULTS
Formation of Conjugated Bilirubin by MH ICI
Cells in Culture
The rate of appearance of conjugated bilirubin
in culture medium is shown in Figs. 1 and 2.
Formation of conjugate occurred at a constant rate
over the first 6-8 hr of incubation with bilirubin
(Fig. 1). After this period, the rate of appearance
of conjugated bilirubin began to decrease (Fig. 2).
No conjugate was identified when unconjugated
bilirubin was incubated with either rat fibroblasts
or medium in the absence of cells .
The decreasing rate of conjugation illustrated
in Fig. 2 is doubtless explained in part by depletion
of bilirubin substrate during prolonged incubation
with MHICI cells. In addition, instability of
unconjugated and/or conjugated bilirubin under
the conditions of culture may have played a role.
No significant deterioration of unconjugated
pigment was observed during a 24 hr incubation
in the absence of cells. However, when medium
from a 30 hr incubation with MH1C1 cells was
incubated for an additional 24 hr in the absence
of cells, the concentration of conjugated bilirubin
decreased at a rate of 2-3 % per hour . Thus, the
amounts of conjugate measured during prolonged
incubation periods are minimal estimates of the
90
4
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6
FIGURE 1 Appearance of conjugated bilirubin in
medium of MHICI cells. Ten replicate flasks of cells
were incubated with F 10 medium containing 5 mg/100
ml of unconjugated bilirubin . At each time interval
shown, the contents of two bottles were removed for
measurement of total cell protein and the concentra-
tion of conjugated bilirubin in the medium . Each point
represents the results from one flask.
2 .5 mg/ I00m1
FIGURE 2 Appearance of conjugated bilirubin in
medium of MHICI cells as a function of time and
unconjugated bilirubin concentration. Duplicate flasks
contained unconjugated bilirubin at concentrations of
1.25, 2.5, and 5.0 mg/100 ml. At each time interval
shown, 0.25 ml of medium was removed from each
flask for measurement of the concentration of conju-
gated bilirubin. Total cell protein was measured at
the end of the experiment.
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705FIGURE 3 Tracings of thin-layer chromatograms of native bile pigments and their diazo-derivatives
from normal rat bile and culture medium from MH1C1 cells that had been incubated with unconjugated
bilirubin (5 mg/100 ml) for 30 hr.
amounts that can actually be conjugated by these
cells.
The formation of conjugate varied directly
with the concentration of unconjugated bilirubin
in the incubation medium over a dose range from
1 .25 to 5.0 mg/100 ml unconjugated bilirubin
(Fig. 2) . At each of these concentrations, approxi-
mately 50% of the total substrate was conjugated
in 30-40 hr . The amount of conjugate formed did
not increase significantly with longer incubation
times, or with further increases in substrate con-
centration.' Indeed, at bilirubin concentrations
of 10 mg/100 ml, MH1C1 cells produced only
small quantities of conjugated bilirubin and
showed morphological signs of cellular injury
when examined by phase-contrast microscopy .
Since the cytotoxicity might have been due to ex-
cess bilirubin unbound to albumin, an experiment
was performed in which bilirubin was dissolved in
a solution containing more than twice the con-
centration of bovine serum albumin than was
routinely employed . Under these conditions,
MH1C1 cells did not show morphological signs of
injury with bilirubin concentrations of 10 mg/100
ml, although they did at 15 mg/100 ml. However,
with the increase in bilirubin concentration to
10 mg/100 ml the formation of conjugated bili-
rubin was no higher than with substrate concentra-
tions of 5 mg/100 ml . Therefore, under the condi-
tions of these experiments, bilirubin conjugation
4 In three experiments, cells were grown in Dul-
becco's rather than in F 10 medium. MH1CI cells
grow two to three times more rapidly and reach a
higher cell density in Dulbecco's medium (4). Under
these conditions, up to 80% of the bilirubin substrate
was conjugated after 38 hr.
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by MH1C1 cells in culture appeared to be maximal
with a bilirubin concentration of 5 mg/100 ml . In
all subsequent experiments, bilirubin conjugation
was assessed in the presence of 5 mg/100 ml of
bilirubin during the first 6 hr of incubation, i .e.
during the linear portion of the curve (Fig. I).
Under these conditions, the rate of formation of
conjugated bilirubin in 22 consecutive experi-
ments varied from 2.4 to 7.1 jug of conjugated
bilirubin per mg cell protein per hour, with a
mean value of 4.4.
The conjugated pigment formed by MH 1C1
cells was further characterized by chromatographic
analysis, with the pigments in normal rat bile as
a standard of comparison . Fig. 3 shows the results
of thin-layer chromatography of both the native
bile pigments and their diazo-derivatives isolated
from medium that had been incubated with
MH1C1 cells for 30 hr. Bands corresponding to
conjugated bilirubin (pigments I and II) and to
the diazo-derivative of conjugated bilirubin were
readily identified. The relatively large quantities
of unconjugated bilirubin and the diazo-derivative
of unconjugated bilirubin in the culture medium
as compared to rat bile are attributable to the
excess of unconjugated bilirubin substrate in the
medium.
Effect of Drugs on Bilirubin Conjugation by
Cells in Culture
When incubated with MH1C1 cells for 6 hr, nei-
ther phenobarbital nor hydrocortisone significantly
affected bilirubin conjugation, although the
former may have had a small enhancing effect
(Table I). Similarly, there was no change in cell
protein in these short-term incubations . In cells
pretreated with phenobarbital for 8 days, cellFIGURE
TABLE I
Effects of Phenobarbital and Hydrocortisone on Bilirubin Conjugation by MH1C1 Cells
HOURS
4 Effect of flavaspidic acid-N-methylglu-
caminate on bilirubin metabolism by MH1C1 cells in
culture. The drug together with 5 mg/100 ml of un-
conjugated bilirubin was added to medium at zero
time. Measurements were made as described in Fig. 2.
protein remained unchanged, but there was a
small increase in the capacity to conjugate bili-
rubin (Table I) . After pretreatment with hydro-
cortisone for 8 days, there was a decrease in cell
protein. Thus, although the total formation of
conjugated bilirubin diminished slightly, there was
actually an increase in bilirubin conjugation per
mg cell protein in these cultures (Table I) .
As shown in Fig . 4, flavaspidic acid at a con-
centration of 5 mg/100 ml reduced the formation
of conjugated bilirubin to less than 25% of that
in control cultures. At a concentration of 1 mg/100
ml, a smaller effect was noted. Flavaspidic acid
(5 mg/100 ml) had no inhibitory effect on serum
albumin production by MH1C1 cells, indicating
* The drug was present in the medium together with unconjugated bilirubin during the 6 hr incubation.
$ The drug was not present during the 6 hr incubation with unconjugated bilirubin .
§ The concentration of unconjugated bilirubin in the medium was 5 mg/100 ml. All flasks were replicated
from the same subculture. Each value given is the result from a single flask .
that the suppression of bilirubin metabolism was
not due to a nonspecific toxic effect of the agent.
Bilirubin UDP-Glucuronyl Transferase in
Homogenates of MH,C1 Cells
Enzyme activity in 14 separate pools of cells var-
ied from 1 .2 to 7.6 yg of conjugated bilirubin
formed per mg cell protein per hour, with a mean
value of 3.3. This value is in good agreement with
bilirubin conjugation by cells in culture (4.4 t
0.20 µg of conjugated bilirubin/mg cell protein/hr,
mean f SE). Rat fibroblasts had no detectable
bilirubin glucuronyl transferase activity .
Pretreatment with phenobarbital for 8 days
did not lead to an increase in bilirubin glucuronyl
transferase activity (Table II) . After 8 days of
pretreatment with hydrocortisone (Table III),
there was a decrease in cell protein and a rise in
bilirubin conjugation per mg cell protein, as had
been observed in the experiments with intact cells
(Table I).
DISCUSSION
These experiments provide the first evidence for
bilirubin conjugation by cells in culture . On
incubation with unconjugated bilirubin, the
MH1C1 strain of rat hepatoma cells produced
conjugated pigments identical with those found
in normal rat bile using two different thin-layer
chromatographic systems (Fig . 3) . Moreover,
bilirubin UDP-glucuronyl transferase activity
was demonstrated in homogenates of MH1C1
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6 hr incubation with drug* 8 days pretreatment with drugs
Treatment Cell protein Conjugated bilirubin) Cell protein Conjugated bilirubin§
mg/flask pg/hr/flask ;4g/mg protein/hr mg/flask pg/hr/flask µg/mg protein/hr
Control 2 .2 6 .2 2 .8 2.4 6 .9 2 .9
2 .3 7 .6 3 .3 2.4 7.6 3 .2
Phenobarbital 2 .2 7.9 3 .6 2 .4 9 .6 4 .0
2 .2 8 .1 3 .7 2 .7 8 .5 3 .2
Hydrocortisone 2.1 6 .2 2 .9 1 .4 5 .6 4 .1
2.3 8 .1 3 .5 1 .3 6 .6 4 .9TABLE II
Effects of Phenobarbital on Bilirubin UDP-Gluc-
uronyl Transferase Activity in MH1C1 Cells
Cultures were treated with phenobarbital (9 .6 X
10-4 M) for 8 days. Cells from six to eight replicate
flasks were pooled, washed, and transferase activity
was determined on the homogenates. Control cells
were handled in the same manner except that they
were not treated with phenobarbital. Each value
is the mean of duplicate determinations.
TABLE III
Effects of Hydrocortisone on Bilirubin UDP-Gluc-
uronyl Transferase Activity in MH1C1 Cells
708
Cultures were treated with hydrocortisone (3 X
10-1 M) for 8 days. Cells from six to eight replicate
flasks were pooled, washed, and transferase ac-
tivity was determined on the homogenates. Con-
trol cells were handled in the same manner except
that they were not treated with hydrocortisone .
Each value is the mean of duplicate determina-
tions.
cells, and the activity was comparable to that
found in normal rat liver. Enzyme activity in
MH1C1 cells varied from 1 .2 to 7.6 .tg of bilirubin
conjugated per mg of cell protein per hour; meas-
ured in the same way, bilirubin glucuronyl
transferase activity in homogenates of liver from
five Sprague-Dawley rats ranged from 3 .1 to 8.4
µg per mg of liver protein per hour (Robinson,
S. H., unpublished data) .
The conversion of unconjugated to conjugated
bilirubin by MH1C1 cells demonstrates the pres-
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ence of pathways for bilirubin uptake and secre-
tion as well as conjugation in these cells . Although
several mechanisms have been proposed for the
inhibition of bilirubin excretion by flavaspidic
acid (17), interference with hepatic uptake seems
the most likely (16) . The inhibition observed
when MH1C1 cells were incubated with flavaspidic
acid (Fig. 4), therefore, suggests that the uptake
process in MH1C1 cells may be similar to that in
normal liver. Since flavaspidic acid has been
shown to compete with bilirubin for binding to
small cytoplasmic proteins which may play a role
in this metabolic process (18), the present findings
further suggest that these proteins are also present
in the cultured cells .
Although the normal mechanism for secretion
of conjugated bilirubin may also be intact in
MH1C1 cells, the conditions of dispersed cell cul-
ture make it difficult to evaluate this aspect of the
excretory process. In intact rats, secretion of
conjugated bilirubin into the bile is the rate-limit-
ing step in hepatic bilirubin excretion (19-21) .
The maximum rate of secretion of conjugated
pigment into the bile in vivo is substantially lower
that the capacity for bilirubin conjugation (22),
and conjugated pigment that cannot gain access
to the bile is "regurgitated" back into the plasma
(19, 21, 22). With MH1C1 cells, on the other hand,
the rate of appearance of conjugated bilirubin
in the medium is similar to the rate of conjugation
by cell homogenates. It seems possible that the
egress of conjugated bilirubin from the cells in cul-
ture may occur by more than one pathway, in-
cluding both secretion and "regurgitation,"
without the anatomic diversion into bile and
plasma found in liver cells in vivo. Under the
conditions of cell culture, therefore, conjugation
rather than secretion might become the limiting
step in bilirubin excretion.
A variety of conditions affected bilirubin
metabolism by MH1C1 cells. The rate of appear-
ance of conjugated bilirubin in the medium varied
with the substrate concentration, and maximal
rates were observed at a bilirubin concentration
of 5 mg/100 ml (Fig . 2). Although this may
indicate that the amount of substrate limits the
rate of conjugation, the complexity of the system
makes interpretation uncertain. Higher substrate
concentrations were associated with morphological
evidence of cell damage, and it is possible that
more subtle changes may have occurred in some
of the other experiments. In addition, the binding
Cell protein Transferase activity
Exp. No. Control
Pheno-
barbital
Pheno-
Control
	
barbital
mg
gg conj. bili ./mg
protein/hr
1 10.5 11 .5 1 .5
	
1 .5
2 5.5 4 .0 3 .1
	
2 .9
3 13 .0 14 .5 1 .3
	
1 .6
Cell protein Transferase activity
Exp. No. Control
Hydro-
cortisone
Hydro-
Control
	
cortisone
mg
Jsg conj. bili.lmg
protein/hr
1 1 .0 0.8 5 .3
	
7 .7
2 1 .0 0.5 4.1
	
7 .8
3 4.4 2.9 1 .2
	
4.1affinity of albumin for bilirubin probably plays a
role in governing the rate of pigment uptake by
liver cells. Since this affinity varies with the species
from which the albumin is derived (23, 24), it is
possible that the use of bovine rather than rat
albumin as a vehicle may have affected the results.
Phenobarbital treatment of intact animals leads
to a significant rise in the capacity to conjugate
bilirubin (22, 25-27) . In the present experiments,
however, there was little or no enhancement of
either enzyme activity in cell homogenates or
bilirubin conjugation by cultured cells after 8 days
of treatment with this drug (Tables I and II) . It
is possible that stimulation did not occur because
the MH1C1 cells are neoplastic and have lost their
responsiveness to this agent. Alternatively, enzyme
activity may already be maximal under the condi-
tions of culture.
The specific activity of bilirubin glucuronyl
transferase did increase after hydrocortisone
treatment (Tables I and III) . However, this
enhancement was more apparent than real, and
resulted primarily from a decrease in cell protein.
As shown in Table I, total bilirubin conjugation
by cells in culture actually decreased somewhat
after prolonged treatment with hydrocortisone .
These findings are consistent with the hypothesis
that, as compared to the soluble proteins, a mem-
brane-bound enzyme such as glucuronyl trans-
ferase is relatively little affected by the anti-
anabolic effect of hydrocortisone .
These experiments demonstrate both similarities
and differences between MH1C 1 cells in culture
and normal rat liver with regard to bilirubin
metabolism. Pigment uptake and conjugation
are similar in many respects in these two systems,
although there is but little enhancement of bili-
rubin conjugation by phenobarbital in MH1C1
cells. Secretion of conjugated bilirubin may also
be intact, but may be obscured by additional
routes of bilirubin egress from the cultured cells.
In addition, preliminary experiments indicate
that MH1C1 cells synthesize labeled bilirubin
from both glycine-214C and delta-aminolevulicin
acid-3,5-3H, demonstrating that these cells also
contain the as yet unidentified heme sources of the
hepatic fraction of early-labeled bilirubin (28) .
For these reasons and because they are a clonai
strain of hepatic parenchymal cells whose environ-
ment can be modified according to experimental
design, MH1C1 cells should prove of great value
in future studies of hepatic bilirubin metabolism.
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